Family Legacy Financial Solutions LLC Invests $5.35 Million in Revvity Inc. $RVTY

Key Points

• Family Legacy Financial Solutions LLC has invested $5.35 million in Revvity Inc., acquiring 54,208 shares, which constitutes about 4.5% of its investment portfolio.
• The company reported earnings of $1.18 per share for the last quarter, surpassing analysts' expectations, with revenue increasing by 4.1% year-over-year to $720.28 million.
• Revvity has announced a quarterly dividend of $0.07 to be distributed on November 7th, representing an annualized dividend yield of 0.3%.

Family Legacy Financial Solutions LLC acquired a new stake in Revvity Inc. (NYSE:RVTY - Free Report) in the second quarter, according to its most recent filing with the SEC. The fund acquired 54,208 shares of the company's stock, valued at approximately $5,351,000. Revvity makes up 4.5% of Family Legacy Financial Solutions LLC's holdings, making the stock its 7th largest holding.

Other hedge funds have also bought and sold shares of the company. Vermillion Wealth Management Inc. purchased a new position in shares of Revvity during the 4th quarter valued at $41,000. New Age Alpha Advisors LLC purchased a new position in Revvity in the first quarter worth $44,000. Continuum Advisory LLC grew its position in Revvity by 39.3% in the fourth quarter. Continuum Advisory LLC now owns 471 shares of the company's stock worth $53,000 after acquiring an additional 133 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company's stock worth $73,000 after acquiring an additional 140 shares in the last quarter. Finally, Cary Street Partners Investment Advisory LLC purchased a new position in Revvity in the first quarter worth $75,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Price Performance

Shares of NYSE:RVTY traded down $0.38 on Monday, reaching $86.34. The company's stock had a trading volume of 327,676 shares, compared to its average volume of 1,195,234. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $129.50. The company has a market cap of $10.02 billion, a P/E ratio of 36.56, a PEG ratio of 2.33 and a beta of 0.94. The company has a 50-day simple moving average of $90.03 and a 200 day simple moving average of $95.07. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm had revenue of $720.28 million during the quarter, compared to analysts' expectations of $711.26 million. During the same period in the previous year, the company earned $1.22 EPS. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, equities research analysts anticipate that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be issued a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity's payout ratio is currently 11.86%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on RVTY. Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 3rd. Evercore ISI lowered their price target on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Raymond James Financial reissued an "outperform" rating and issued a $115.00 price target (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Stifel Nicolaus lowered their price target on shares of Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research note on Tuesday, July 29th. Finally, Bank of America lowered their price target on shares of Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Ten equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $120.07.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.